Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Abbott Laboratories (NY:ABT)

133.16 -0.58 (-0.43%)
Streaming Delayed Price Updated: 1:31 PM EDT, Oct 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9
...
43 44 Next >
3 Dividend Stocks to Double Up On Right Now
The time is right for buying more of these great dividend stocks. 
Via The Motley Fool
Topics Economy Energy
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Breakthrough in Alzheimer’s Diagnostics: University of Liverpool Unveils Low-Cost, Handheld AI Blood Test
In a monumental stride towards democratizing global healthcare, researchers at the University of Liverpool have announced the development of a pioneering low-cost, handheld, AI-powered blood test... 
Via TokenRing AI
Topics Artificial Intelligence
Healthcare Sector Shines Amidst Market Turbulence, Bolstering S&P 500 Resilience
On October 2, 2025, the Healthcare sector emerged as a beacon of stability and growth within the S&P 500, delivering a robust positive performance that significantly contributed to the broader market's... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
2 Profitable Stocks to Consider Right Now and 1 We Find Risky
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
Via StockStory
1 Top ETF I Wouldn't Hesitate to Invest $1,000 Into Right Now
This fund makes it easy to invest in the top dividend stocks. 
Via The Motley Fool
Topics ETFs Stocks
Abbott India Limited: A Deep Dive into its Robust Forecast and Valuation Outlook Amidst a Thriving Indian Pharma Market
Mumbai, India – September 27, 2025 – Abbott India Limited (NSE: ABBOTINDIA), a prominent player in the Indian pharmaceutical sector, is exhibiting a robust financial trajectory and a promising... 
Via MarketMinute
Topics Economy Intellectual Property
Abbott Laboratories (NYSE:ABT) Passes the Caviar Cruise Quality Investing Screen
Discover Abbott Laboratories (ABT), a top Caviar Cruise screen pick. This healthcare leader excels in profitability, financial health, and cash flow, making it a strong long-term quality investment. 
Via Chartmill
1 Unpopular Stock That Deserves Some Love and 2 We Avoid
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other... 
Via StockStory
Topics Retirement
Abbott Laboratories (NYSE:ABT) Presents a Technical Breakout Setup for Investors
Abbott Laboratories (ABT) is a technical breakout candidate, showing a strong uptrend and a perfect consolidation setup, suggesting a potential upward move. 
Via Chartmill
The Magnificent 7 Boom Just Triggered A Dot-Com Era Warning
The Magnificent Seven tech giants are now worth $21 trillion—8x more than top health care stocks, echoing dot-com bubble extremes. 
Via Benzinga
Don't Overlook These 2 Dividend Kings in Today's Volatile Market
These businesses may be "boring," but that's a good thing in today's market. 
Via The Motley Fool
Topics Economy Government World Trade
8 Dividend Growth Stocks Every Investor Should Consider
These dividend powerhouses compound wealth through decades of consecutive increases and sustainable payout ratios. 
Via The Motley Fool
Topics Artificial Intelligence Economy
Navigating the Emotional Tides: Investor Psychology in a Volatile Market
The financial markets are currently a tempestuous sea, marked by a perplexing interplay of underlying strength and overt volatility, largely driven by the powerful forces of investor psychology. As of... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
Short Report Alleges Dexcom Sold Faulty G7 Device Cited By FDA
Dexcom faces mounting scrutiny over G7 safety concerns, FDA violations, financial practices, and growing competition from Abbott's Libre 3. 
Via Benzinga
September's Shadow: Will the Notorious 'September Effect' Offer Bargains or Bring Bigger Bears to Wall Street?
As autumn leaves begin to fall, a familiar chill often descends upon the financial markets, not just in temperature but in investor sentiment. September has historically earned a notorious reputation... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
3 No-Brainer Dividend Stocks to Buy in September
The attraction of these dividend stocks isn't limited to their dividends. 
Via The Motley Fool
Topics Intellectual Property
Texas Rep. Julie Johnson Sold Up to $885K Worth of 3M Stock
 
Via Benzinga
3 S&P 500 Stocks to Keep an Eye On
The biggest companies in the world call the S&P 500 (^GSPC) home, but only a handful are still growing rapidly. Some of these industry leaders are executing exceptionally well and rewarding... 
Via StockStory
Topics Artificial Intelligence Stocks
1 Reason Every Investor Should Know About AbbVie (ABBV)
This company's past ability to extend patent-protected market exclusivity for its drugs bodes well for new investors. 
Via The Motley Fool
Topics Intellectual Property
3 Dividend Stocks to Double Up on Right Now
Investors can feel good about upping their bets on these great dividend stocks. 
Via The Motley Fool
Topics Energy Intellectual Property
Could These 3 Dividend Kings Be Worth $1 Trillion in 10 Years?
There is more to like than the dividend with these companies. 
Via The Motley Fool
Topics Intellectual Property
Peering Into Abbott Laboratories's Recent Short Interest
 
Via Benzinga
5 High-Yield Dividend Stocks I Plan on Holding for the Next 10 Years or Longer
Selling these dividend stocks isn't on my radar at all. 
Via The Motley Fool
Topics Energy Intellectual Property
If You'd Invested $1,000 in DexCom 10 Years Ago, Here's How Much You'd Have Today
The company's innovative devices have helped it generate decent performances. 
Via The Motley Fool
2 Reasons to Watch ABT and 1 to Stay Cautious
Abbott Laboratories currently trades at $131.61 per share and has shown little upside over the past six months, posting a small loss of 4.6%. The stock also fell short of the S&P 500’s 8.8% gain during... 
Via StockStory
Topics Stocks Supply Chain
EU Rushes To Scrap Tariffs On US Goods To Unlock Lower American Auto Duties: These Exporters Stand To Gain Big
EU set to scrap tariffs on U.S. goods in a key auto trade deal. See which American industrial and energy stocks are poised for a boost. 
Via Benzinga
Topics World Trade
Navigating the Currents: Top Sectors Primed for Growth in Q3 2025
The global economy is sailing into Q3 2025 with a blend of cautious optimism and persistent challenges. While a new tariff regime and elevated geopolitical tensions introduce elements of uncertainty,... 
Via MarketMinute
Topics Artificial Intelligence Economy Retirement
3 Unstoppable Dividend Stocks to Buy Right Now
Investors will get great dividends and more with these stocks. 
Via The Motley Fool
Topics World Trade
2 High-Yield Dividend Stocks to Buy in August and Hold for a Decade or Longer
These high-yield dividend stocks are built to last. 
Via The Motley Fool
Topics Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9
...
43 44 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.